BioSpace News Archive

Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the quarter ended September 30, 2021.

Sonendo, Inc. today announced the appointment of Raj Pudipeddi as a member of its Board of Directors.

Can-Fite BioPharma Ltd today announced the last of approximately 400 psoriasis patients enrolled in its Phase III Comfort™ study is scheduled to complete a 16-week cycle of treatment with Piclidenoson, the Company’s lead drug candidate, at the beginning of January 2022.

Samsung Biologics, the world’s leading contract development and manufacturing organization, held an award ceremony with the British Standard Institution at its Songdo headquarters for global ISO9001 certification in recognition of the company’s Quality Management System.

Vaginal speculum is a metallic device used to open the orifice of vagina, inspect the vaginal wall and cervix, and collect cervical cells for Pap smear test, a diagnostic examination for cervical cancer in women.

Odyssey Therapeutics today announced the completion of an oversubscribed $218 million Series A financing led by OrbiMed Advisors and co-led by SR One Capital Management with participation from Foresite Capital, Woodline Partners LP, Logos Capital, HBM Healthcare Investments, Colt Ventures, Creacion Ventures, and other institutional investors.

ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organisations, is proud to announce it was named the “Best Contract Research Organisation” of 2021 during the 17th Annual Scrip Awards ceremony on 2 December.

Immunome, Inc. today announced that members of management will participate in a fireside chat hosted by Cantor Fitzgerald Analyst Brian Cheng on Wednesday, December 8, 2021 at 1:00 p.m. ET.

GATC Health today announced that Preetaman Wadhwa has joined the company as the Chief Marketing Officer.

Foldax® , Inc. today announced that the Drugs Controller General of India (DCGI), India’s regulatory body for medical devices, has approved initiation of a clinical trial of the TRIA™ biopolymer surgical aortic heart valve.